AIPLA tells US Congress: We cannot support Innovation Act
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

AIPLA tells US Congress: We cannot support Innovation Act

AIPLA has written to Congress saying it cannot support the Innovation Act because of objections to several provisions within the bill and the speed with which the legislation has moved forward.

The association, which represents about 15,000 lawyers and other IP professionals, urged Congress to “take a balanced approach that also continues to encourage innovation” when considering the bill, otherwise known as H.R. 3309.

In the letter, sent yesterday, AIPLA made suggestions including:


· Ensure that Section 3 and Section 6 do not “interfere with the traditional discretion of the courts by avoiding inflexible legislatively mandated rules.” Section 3 would require more transparency in claims and oblige patent holders making claims not “reasonably justified in law and fact” to pay the other party’s attorneys fees.

· Retain Section 9(c), which would require the USPTO to use the same claim construction standard in inter partes and post-grant review as is used by district courts. At present, the USPTO uses the “broadest reasonable interpretation” standard, which is designed to prevent overly broad claims and is less advantageous to patent holders than the standard used by the district courts.

· Rewrite Section 5, which allows courts to stay suits against customers when there is parallel litigation against a manufacturer, so that is “not so overbroad that genuine infringers receive the protection intended for the innocent.”

· Remove Section 9(a), which strikes Section 145 of the AIA. Section 145 allows patent applicants to challenge the USPTO’s refusal of a patent application in district court after appealing to the USPTO’s Patent Trial and Appeal Board (PTAB). (Other potential recourses for applicants include appealing directly to the Federal Circuit under Section 141 or filing a continuation application.)

· Retain Section 9(b), which would strike “or could reasonably have raised” from the estoppel provisions of 35 USC Section 325. AIPLA claims this would encourage those challenging patents to do so in the early stages of the patent term, “when reliance, commercialisation and related investment are likely at their minimum.”

· Give further consideration to other provisions, such as Section 9(d) on double patenting, Section 9(f) on patent term adjustment, and Section 9(g) on clarification of jurisdiction.

AIPLA also said it was disappointed the bill did not “secure full funding” for the USPTO. The organisation has been campaigning to have the USPTO exempted from budget sequestration.

more from across site and ros bottom lb

More from across our site

High-earning businesses place most value on the depth of the external legal teams advising them, according to a survey of nearly 29,000 in-house counsel
Kilpatrick Townsend was recognised as Americas firm of the year, while patent powerhouse James Haley won a lifetime achievement award
Partners at Foley Hoag and Kilburn & Strode explore how US and UK courts have addressed questions of AI and inventorship
In-house lawyers have considerable influence over law firms’ actions, so they must use that power to push their external advisers to adopt sustainable practices
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Counsel say they’re advising clients to keep a close eye on confidentiality agreements after the FTC voted to ban non-competes
Data from Managing IP+’s Talent Tracker shows US firms making major swoops for IP teams, while South Korea has also been a buoyant market
The finalists for the 13th annual awards have been announced
Counsel reveal how a proposal to create separate briefings for discretionary denials at the USPTO could affect their PTAB strategies
The UK Supreme Court rejected the firm’s appeal against an earlier ruling because it did not raise an arguable point of law
Gift this article